Participants 39 71 3
patients with serious infections
Participants 240 328 4
consecutive patients with serious infections for whom an aminoglycoside seemed warranted
Participants 330 401 4
Exclusion criteria were neutropenia or severely impaired renal function
Participants 403 429 5
123 patients were enrolled
Participants 465 567 5
atients were considered in whom treatment with the aminoglycoside was not stopped within 72 h (n = 67)
Participants 594 699 5
patients receiving aminoglycosides for more than 48 h and not using other nephrotoxic medication (n = 85)
